Skip to main content

letter

. 1983 Dec 3;287(6406):1716–1717. doi: 10.1136/bmj.287.6406.1716-c

Intermittent cyclophosphamide in refractory rheumatoid arthritis.

R Madhok, H Capell

PMCID: PMC1550161 PMID: 6416556

1716

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Baltus J. A., Boersma J. W., Hartman A. P., Vandenbroucke J. P. The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up. Ann Rheum Dis. 1983 Aug;42(4):368–373. doi: 10.1136/ard.42.4.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
Kinlen L. J., Sheil A. G., Peto J., Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J. 1979 Dec 8;2(6203):1461–1466. doi: 10.1136/bmj.2.6203.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
Pinals R. S., Masi A. T., Larsen R. A. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum. 1981 Oct;24(10):1308–1315. doi: 10.1002/art.1780241012. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES